Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WCC✓SelectedUSD · WCCGSK vs WCC performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs WCC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+55.4%
WCC return
+111.9%
Excess return
-56.5%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioWCCExcessAlpha
1D-1.3%-0.4%-0.9%-1.3%
7D-3.1%-4.2%+1.1%-3.1%
30D-0.9%-8.3%+7.4%-1.0%
3M-4.2%-10.1%+5.9%-4.3%
6M-1.6%-9.6%+8.0%-1.8%
YTD+2.6%+28.8%-26.2%+0.8%
1Y+6.2%+26.7%-20.5%+4.5%
All+55.4%+111.9%-56.5%+42.8%

Cumulative growth

Daily Returns

Daily percentage return beside WCC.

Daily Out/Under-Performance

Portfolio return minus WCC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WCC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded WCC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling